OCTALFA

ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus on developing optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.

Mathym is a biomedical company that develops and supplies colloidal nanomaterials for dental applications.

ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus on developing optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.

NightSwapping is a community of over 150,000 members who swap nights to travel and stay for free at each other's places. With money out of the equation, hosts and travelers can enjoy a truly authentic experience with no legal issues. And when don't know where want to go, it's easy! Just let them surprise with suggestions of unexpected & exciting destinations!

Mathym is a biomedical company that develops and supplies colloidal nanomaterials for dental applications.

e(ye)BRAIN is a medical company that manufactures and distributes eye trackers for its clients. e(ye)BRAIN’s range of products include Eye Brain T1 and T2. The T1 enables its users to record eye movements. T2 uses algorithms to enable its users to record eye and head movements. The recorded movements will be analyzed by a software called MeyeEval. The company offers advisory, paradigm development, formation, and support services to its clients. e(ye)BRAIN was founded in 2008 by Serge Kinkingnehun and is based in France.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.

Laboratories JUVISE Pharmaceuticals is a multinational pharmaceutical company that specialises in acquiring, manufacturing and marketing treatments offering great therapeutic potential for patients around the world. Following the sale of Lynapharm laboratories to the Italian pharmaceutical group Sigma-Tau in 2008, Mr Mascha established JUVISE Pharmaceuticals company as an international pharmaceutical subsidiary of the JUVISE group. JUVISE Pharmaceuticals is a pharmaceutical company accredited by the ANSM, French National Agency for the Safety of Medicines and Health Products. The company specialises in manufacturing and marketing pharmaceutical products to treat cardiologic, psychiatric, rheumatic and respiratory/ENT conditions and also fertility/sexual matters. JUVISE Pharmaceuticals currently markets 8 speciality pharmaceutical products: Esidrex®, Sintrom®, Digoxin®, Entumin®, Insidon®, Lumirelax®, Calmixène®, Extovyl®. It also markets two food supplements: Proxeed®Plus and Proxeed®Women. These are sold in a total of 57 countries.

Graftys, an Aix-en-Provence, France-based early stage company focused on advanced bone biologics.

Orega Biotech is a biotech company committed to the development of immunotherapeutics for the treatment of cancer. Backed by INSERM-Transfert and OCTALFA, Orega Biotech was set up in March 2010 at the initiative of its four founders bringing together scientific and business skills. The company specializes in the development of monoclonal antibodies for cancer immunotherapy. Focusing on tumor microenvironment, the company's target discovery program aims at discovering and validating novel clinically-relevant cancer targets. Orega Biotech is headquartered in Écully, France.

Docea Power develops and markets software solutions for power and thermal analysis at the architectural level. It offers Aceplorer, an electronic system level solution for modeling, exploration, and optimization of power and thermal behavior of various electronic system architectures. The company’s solution allows the modeling of heterogeneous systems with a mix of digital, analog, or mixed signal blocks and with different levels of models complexity. It also provides training and consultancy services. The company’s product is used by OEMs, SiP and SoC manufacturers, and IP and IC providers. It serves wireless, automotive, consumer, aerospace, computing, and medical markets.

Glycode SAS, a biotechnology company, operates in the field of protein glycosylation in France. It provides and licenses GlycodExpress, a yeast based technological platform for the production of recombinant therapeutic glycoproteins for therapeutic purposes, such as antibodies, EPOs, and growth factors, as well as allows humanization of N-glycosylation in Saccharomyces cerevisiae. The company also offers on-demand production and purification services, from the conception and synthesis of optimized expression vectors for protein expression in glycoengineered yeasts to the early steps of production process. Glycode SAS serves biotechnology and pharmaceutical companies. The company was founded in 2004 and is based in Uzerche, France.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.

ANTAGENE is a biotechnology company which develops and sells DNA tests witin the framework of animal health, tracability and veterinary diagnosis. ANTAGENE is the expert of the detection of genetic diseases and the genetic identification in dog and cat. ANTAGENE aims at developing and selling a full range of DNA tests to detect the most gravous genetic diseases for dogs and cats health and wellness. Thanks to these DNA tests breeder prematurely select the breeding animals and then avoid breeding puppies or kittens suffering from an incapaciting disease. The generalization of this early detection will enable to limit the spread of the genetic anomaly in breedings and the breed.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.

Ipsogen is develops and markets diagnostic tests in the field of oncology worldwide. The company offers diagnostic kits and biomarkers. Its products are used in the diagnosis, prognosis, and monitoring of patients with leukemia.